DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactResults

Bliss GVS Pharma Limited — Board Meeting Intimation

NSE 1 hr ago·5 Aug 2026, 11:39 am

Bliss GVS Pharma

Bliss GVS Pharma has announced a board meeting scheduled for August 12, 2026. The primary agenda for this meeting is to review and approve the company's unaudited financial results for the quarter that ended in June 2026.

This announcement is a routine corporate action that signals the company's upcoming financial reporting cycle. For investors, it provides a timeline to anticipate the release of quarterly performance data, which is a key metric for evaluating the company's current operational health and growth trajectory.

Investors should watch for the release of these results to assess the company's profitability and revenue trends. Market reaction to the earnings report will likely depend on the company's ability to meet or exceed market expectations during this period.